The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
News|Poll|November 17, 2015
Ulcer with an Undermined Edge
Author(s)Francis Christian, MD
The rapidly expanding lesion began as a small boil in the center of the ulcerated area 4 weeks ago. What underlying process do you suspect?
Advertisement
A 50-year-old woman presented with this ulcerative lesion which she said began approximately one month ago as a small “boil” in the center of the now-enlarged area. She squeezed the initial lesion and treated it with topical antibiotic ointment. The lesion progressively expanded and became extremely painful.
What does this look like to you?
Advertisement
Related to this article
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
2
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
ACCORD Trials: Efficacy and Safety of Dextromethorphan-Bupropion in Agitation
5